T. Rowe Price Health Sciences Fund (PRHSX)
Ticker Symbol:
Fund Status:
Open to new Retail investors  /  Open to subsequent Retail investments
Fund Composition
Asset Allocation
as of 12/31/2013
Volatility and Other Measures
as of 02/28/2014
Beta 0.92
Standard Deviation 14.62
Price/Earnings Ratio (Domestic) 22.4
Earnings Growth Rate (Domestic) 14.8
Turnover Rate 63.8
Median Market
$22,239.9 Million
10 Largest Holdings
Represents 35.22 % of Total Net Assets
View Holdings as of:
Actavis plc
Agilent Technologies
Alexion Pharmaceuticals
Biogen Idec
Gilead Sciences
Incyte Corp
UnitedHealth Group
Valeant Pharmaceuticals International
As of 03/31/2014 the Health Sciences Fund had a total of 152 holdings.
Sector Diversification
as of 02/28/2014
% of Total Net Assets
Biotechnology 34.8%
Services 24.4%
Pharmaceuticals 20.3%
Products & Devices 10.5%
Life Sciences 6.2%
Miscellaneous 1.1%
See Glossary for additional details on all data elements.